Agilon Intangible Assets from 2010 to 2026
| AGL Stock | USD 0.62 0.03 5.08% |
Intangible Assets | First Reported 2018-12-31 | Previous Quarter 75.3 M | Current Value 65.7 M | Quarterly Volatility 25.8 M |
Check Agilon Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Agilon Health's main balance sheet or income statement drivers, such as Tax Provision of 1.1 M, Interest Income of 8.5 M or Discontinued Operations of 561.5 K, as well as many indicators such as Price To Sales Ratio of 0.0457, Dividend Yield of 0.0 or PTB Ratio of 2.36. Agilon financial statements analysis is a perfect complement when working with Agilon Health Valuation or Volatility modules.
Agilon | Intangible Assets | Build AI portfolio with Agilon Stock |
Historical Intangible Assets data for Agilon Health serves as a key indicator of operational performance and financial stability. Tracking changes in this metric over time helps investors spot emerging trends before they become obvious, providing an edge in assessing whether agilon health represents a compelling investment opportunity.
Latest Agilon Health's Intangible Assets Growth Pattern
Below is the plot of the Intangible Assets of agilon health over the last few years. It is non-physical assets possessed by a company, such as patents, trademarks, and copyrights, which provide long-term value. Agilon Health's Intangible Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Agilon Health's overall financial position and show how it may be relating to other accounts over time.
| Intangible Assets | 10 Years Trend |
|
Intangible Assets |
| Timeline |
Agilon Intangible Assets Regression Statistics
| Arithmetic Mean | 67,113,151 | |
| Geometric Mean | 64,393,085 | |
| Coefficient Of Variation | 22.84 | |
| Mean Deviation | 8,918,963 | |
| Median | 71,146,000 | |
| Standard Deviation | 15,326,417 | |
| Sample Variance | 234.9T | |
| Range | 78.5M | |
| R-Value | (0.31) | |
| Mean Square Error | 227.2T | |
| R-Squared | 0.09 | |
| Significance | 0.23 | |
| Slope | (927,121) | |
| Total Sum of Squares | 3758.4T |
Agilon Intangible Assets History
About Agilon Health Financial Statements
Agilon Health investors utilize fundamental indicators, such as Intangible Assets, to predict how Agilon Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Intangible Assets | 65.7 M | 51.3 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out the analysis of Agilon Health Correlation against competitors. For more information on how to buy Agilon Stock please use our How to buy in Agilon Stock guide.You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agilon Health. If investors know Agilon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Agilon Health assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth 11.951 | Earnings Share (0.78) | Revenue Per Share | Quarterly Revenue Growth 0.031 | Return On Assets |
Investors evaluate agilon health using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Agilon Health's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Agilon Health's market price to deviate significantly from intrinsic value.
Understanding that Agilon Health's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Agilon Health represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Agilon Health's market price signifies the transaction level at which participants voluntarily complete trades.